No abstract

The persistence of eight pharmaceuticals from multiple classes was studied in aquatic outdoor field microcosms. A method was developed for the determination of a mixture of acetaminophen, atorvastatin, caffeine, carbamazepine, levofloxacin, sertraline, sulfamethoxazole, and trimethoprim at microg/L levels from surface water of the microcosms using solid phase extraction and high-performance liquid chromatography-ultraviolet (HPLC-UV) and liquid chromatography tandem mass spectrometry (LC-MS-MS). Half-lives in the field ranged from 1.5 to 82 d. Laboratory persistence tests were performed to determine the relative importance of possible loss processes in the microcosms over the course of the study. Results from dark control experiments suggest hydrolysis was not important in the loss of the compounds. No significant differences were observed between measured half-lives of the pharmaceuticals in sunlight-exposed pond water and autoclaved pond water, which suggests photodegradation was important in limiting their persistence, and biodegradation was not an important loss process in surface water over the duration of the study. Observed photoproducts of several of the pharmaceuticals remained photoreactive, which led to further degradation in irradiated surface waters.

No abstract

A unique configuration of the diffusive gradients in thin films sampler for polar organics (o-DGT) without a poly(ether sulfone) membrane was developed, calibrated, and field-evaluated. Diffusion coefficients (D) through agarose diffusive gels ranged from (1.02 to 4.74) × 10 cm/s for 34 pharmaceuticals and pesticides at 5, 13, and 23 °C. Analyte-specific diffusion-temperature plots produced linear (r > 0.85) empirical relationships whereby D could be estimated at any environmentally relevant temperature (i.e., matched to in situ water conditions). Linear uptake for all analytes was observed in a static renewal calibration experiment over 25 days except for three macrolide antibiotics, which reached saturation at 300 ng (≈15 d). Experimental sampling rates ranged from 8.8 to 16.1 mL/d and were successfully estimated with measured and modeled D within 19% and 30% average relative error, respectively. Under slow flowing (2.4 cm/s) and static conditions, the in situ diffusive boundary layer (DBL) thickness ranged from 0.023 to 0.075 cm, resulting in a maximum contribution to mass transfer of <45%. Estimated water concentrations by o-DGT at a wastewater treatment plant agreed well with grab samples and appeared to be less influenced by the boundary layer compared to that of polar organic chemical integrative samplers (POCIS) deployed simultaneously. The o-DGT sampler is a promising monitoring tool that is largely insensitive to the DBL under typical flow conditions, facilitating the application of measured/modeled diffusion-based sampling rates. This significantly reduces the need for sampler calibration, making o-DGT more widely applicable, reliable, and cost-effective compared to current polar passive samplers.

No abstract

No abstract

This work presents a critical assessment of the state and quality of knowledge around the aquatic photochemistry of human- and veterinary-use pharmaceuticals from laboratory experiments and field observations. A standardized scoring rubric was used to assess relevant studies within four categories: experimental design, laboratory-based direct and indirect photolysis, and field/solar photolysis. Specific metrics for each category are defined to evaluate various aspects of experimental design (e.g., higher scores are given for more appropriate characterization of light source wavelength distribution). This weight of evidence-style approach allowed for identification of knowledge strengths and gaps covering three areas: first, the general extent of photochemical data for specific pharmaceuticals and classes; second, the overall quality of existing data (i.e., strong versus weak); and finally, trends in the photochemistry research around these specific compounds, e.g. the observation of specific and consistent oversights in experimental design. In general, those drugs that were most studied also had relatively good quality data. The four pharmaceuticals studied experimentally at least ten times in the literature had average total scores (lab and field combined) of ≥29, considered decent quality; carbamazepine (13 studies; average score of 31), diclofenac (12 studies; average score of 31), sulfamethoxazole (11 studies; average score of 34), and propranolol (11 studies; average score of 29). Major oversights and errors in data reporting and/or experimental design included: lack of measurement and reporting of incident light source intensity, lack of appropriate controls, use of organic co-solvents in irradiation solutions, and failure to consider solution pH. Consequently, a number of these experimental parameters were likely a cause of inconsistent measurements of direct photolysis rate constants and quantum yields, two photochemical properties that were highly variable in the literature. Overall, the assessment rubric provides an objective and scientifically-defensible set of metrics for assessing the quality of a study. A major recommendation is the development of a method guideline, based on this rubric, for conducting and reporting on photochemical studies that would produce consistent and reliable data for quantitative comparison across studies. Furthermore, an emphasis should be placed on conducting more dual-fate studies involving controlled photolysis experiments in natural sunlight, and whole system fate studies in either natural or artificial systems. This would provide accurate data describing the actual contribution of photolysis to the overall fate of pharmaceuticals in the environment.

No abstract